Top Links

Articles Related to itching

Switching Darunavir/Ritonavir to Darunavir/Cobicistat in Clinical Practice Experience with 150 patients through 48 weeks

Darunavir (DRV) boosted with ritonavir (RTV) is currently among the preferred antiretroviral agents. Cobicistat (COBI), a new cytochrome P450 inhibitor is replacing RTV as pharmacoenhancer. Coformulated DRV/COBI has been approved based on bioequivalence data; however results on efficacy and safety in clinical practice are scarce. COBI inhibits creatinine tubular secretion, thus raising concerns about its renal safety.
View complete article: PDF  |  Full-text

Clinical Evaluation of 762 Single-Tooth, Locking-Taper Implants: A Prospective Study with 1- to 12-Years of Follow-Up

The aim of this study was to evaluate the survival rate, complications and marginal bone loss of single-tooth lockingtaper implants.
View complete article: PDF  |  Full-text

Treatments for Atopic Dermatitis

Atopic dermatitis, also known as eczema, affects about 10-20% of children in the UK and about 1-3% of adults [1]. The incidence of atopic dermatitis has increased as much as 3 fold in the past 40 years
View complete article: PDF  |  Full-text  | Digital
 
 

Fabrication of Ordered Arrays of Anodic Aluminum Oxide Pores with Interpore Distance Smaller than the Pitch of Nano-pits formed by Ion Beam Etching

We investigated a method for preparation of ordered nanopore arrays with the interpore distance of 60 nm by guided self-organization of anodic aluminum oxide with a prepatterned array of pits in the starting Al film.
View complete article: PDF  |  Full-text


Submit Manuscript